Effective mucosal immunization against respiratory syncytial virus using purified F protein and a genetically detoxified cholera holotoxin, CT-E29H

Author： Tebbey P.W.   Scheuer C.A.   Peek J.A.   Zhu D.   LaPierre N.A.   Green B.A.   Phillips E.D.   Ibraghimov A.R.   Eldridge J.H.   Hancock G.E.  

Publisher： Elsevier

ISSN： 0264-410X

Source： Vaccine, Vol.18, Iss.24, 2000-06, pp. : 2723-2734

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A modified cholera holotoxin CT-E29H enhances systemic and mucosal immune responses to recombinant Norwalk virus-virus like particle vaccine

By Periwal S.B.   Kourie K.R.   Ramachandaran N.   Blakeney S.J.   DeBruin S.   Zhu D.   Zamb T.J.   Smith L.   Udem S.   Eldridge J.H.   Shroff K.E.   Reilly P.A.  

Vaccine, Vol. 21, Iss. 5, 2003-01 ,pp. : 376-385

Elsevier

Access to resources Recommend Favorite

Immunization onto shaved skin with a bacterial enterotoxin adjuvant protects mice against Respiratory Syncytial Virus (RSV)

By Godefroy S.   Goestch L.   Plotnicky-Gilquin H.   Nguyen T.N.   Schmitt D.   Staquet M.-J.   Corvaa N.  

Vaccine, Vol. 21, Iss. 15, 2003-04 ,pp. : 1665-1671

Elsevier

Access to resources Recommend Favorite

Safety and immunogenicity of respiratory syncytial virus purified fusion protein-2 vaccine in pregnant women

By Munoz F.M.   Piedra P.A.   Glezen W.P.  

Vaccine, Vol. 21, Iss. 24, 2003-07 ,pp. : 3465-3467

Elsevier

Access to resources Recommend Favorite

Mucosal immunization against hepatitis B virus by intranasal co-administration of recombinant hepatitis B surface antigen and recombinant cholera toxin B subunit as an adjuvant

By Isaka M.   Yasuda Y.   Mizokami M.   Kozuka S.   Taniguchi T.   Matano K.   Maeyama J.-i.   Mizuno K.   Morokuma K.   Ohkuma K.   Goto N.   Tochikubo K.  

Vaccine, Vol. 19, Iss. 11, 2001-12 ,pp. : 1460-1466

Elsevier

Access to resources Recommend Favorite

Dose-dependent effects of IL-12 treatment to immune response induced after immunization with a recombinant respiratory syncytial virus (RSV) fusion protein fragment

By Werle B.   Fromantin C.   Alexandre A.   Kohli E.   Pothier P.  

Vaccine, Vol. 17, Iss. 23, 1999-08 ,pp. : 2983-2990

Elsevier

Access to resources Recommend Favorite